Search

Your search keyword '"Comoli, Patrizia"' showing total 622 results

Search Constraints

Start Over You searched for: Author "Comoli, Patrizia" Remove constraint Author: "Comoli, Patrizia"
622 results on '"Comoli, Patrizia"'

Search Results

2. COVID-19 omicron variant outbreak in a hematopoietic stem cell transplant unit

3. Production of donor-derived cytotoxic T lymphocytes with potent anti-leukemia activity for adoptive immunotherapy in high-risk pediatric patients given haploidentical hematopoietic stem cell transplantation

4. Interface Gain-of-Function Mutations in TLR7 Cause Systemic and Neuro-inflammatory Disease

5. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

6. Wiskott-Aldrich syndrome protein forms nuclear condensates and regulates alternative splicing

7. Feasibility of autologous peripheral blood stem cell mobilization and harvest in adult patients with FLT3-mutated acute myeloid leukemia receiving chemotherapy combined with midostaurin: a single-center experience

10. Comparing BamHI-W and CE-marked assays to detect circulating Epstein-Barr Virus (EBV) DNA of nasopharyngeal cancer patients in a non-endemic area

12. Author Correction: Wiskott-Aldrich syndrome protein forms nuclear condensates and regulates alternative splicing

13. Management of PTLD After HSCT

14. Post-transplant de novo non donor-specific HLA antibodies are not associated with poor graft outcome in non-sensitized pediatric recipients of kidney transplantation

15. Phase I Clinical Trial on Pleural Mesothelioma Using Neoadjuvant Local Administration of Paclitaxel-Loaded Mesenchymal Stromal Cells (PACLIMES Trial): Study Rationale and Design.

16. The IPTA Nashville consensus conference on post‐transplant lymphoproliferative disorders after solid organ transplantation in children: IV‐consensus guidelines for the management of post‐transplant lymphoproliferative disorders in children and adolescents

18. Breast implant surface topography triggers a chronic-like inflammatory response

19. Characterization of Mesenchymal Stromal Cells after Serum Starvation for Extracellular Vesicle Production.

21. Characteristics and clinical behavior of acute myeloid leukemia harboring rare non-A/B/D nucleophosmin ( NPM1 ) gene mutation subtypes: a single-center experience and review of the literature

23. Mesenchimal stromal cells as rescue therapy for refractory Chronic Lung Allograft Dysfunction: preliminary data of an Italian monocentric cohort

24. P1388: EFFECTIVENESS AND SAFETY OUTCOMES IN PATIENTS WITH EBV+ PTLD TREATED WITH ALLOGENEIC EBV-SPECIFIC T-CELL IMMUNOTHERAPY (TABELECLEUCEL) UNDER AN EXPANDED ACCESS PROGRAM IN EUROPE

25. Long-Term Outcomes of Cord Blood Transplantation from an HLA-Identical Sibling for Patients with Bone Marrow Failure Syndromes: A Report From Eurocord, Cord Blood Committee and Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation

26. Efficacy of two different doses of rabbit anti-T-lymphocyte globulin to prevent graft-versus-host disease in children with haematological malignancies transplanted from an unrelated donor: a multicentre, randomised, open-label, phase 3 trial

29. The IPTA Nashville consensus conference on Post‐Transplant lymphoproliferative disorders after solid organ transplantation in children: II—consensus guidelines for prevention.

30. The IPTA Nashville Consensus Conference on Post‐Transplant lymphoproliferative disorders after solid organ transplantation in children: III – Consensus guidelines for Epstein‐Barr virus load and other biomarker monitoring.

32. Clinical Trials of Cellular Therapies in Solid Tumors

33. The IPTA Nashville Consensus Conference on Post‐Transplant lymphoproliferative disorders after solid organ transplantation in children: III – Consensus guidelines for Epstein‐Barr virus load and other biomarker monitoring

34. Potency assays and biomarkers for cell-based advanced therapy medicinal products

35. Preclinical Validation of an Advanced Therapy Medicinal Product Based on Cytotoxic T Lymphocytes Specific for Mutated Nucleophosmin (NPM1mut) for the Treatment of NPM1mut-Acute Myeloid Leukemia

38. Prognostic Relevance of Multi-Antigenic Myeloma-Specific T-Cell Assay in Patients with Monoclonal Gammopathies

41. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

42. Anti-glutathione S-transferase theta 1 antibodies correlate with graft loss in non-sensitized pediatric kidney recipients

43. The IPTA Nashville consensus conference on Post‐Transplant lymphoproliferative disorders after solid organ transplantation in children: II—consensus guidelines for prevention

45. Comparing BamHI-W and CE-marked assays to detect circulating Epstein-Barr Virus (EBV) DNA of nasopharyngeal cancer patients in a non-endemic area

46. Feasibility of autologous peripheral blood stem cell mobilization and harvest in adult patients with FLT3-mutated acute myeloid leukemia receiving chemotherapy combined with midostaurin: a single-center experience

47. Long-lasting responses with chemotherapy followed by T-cell therapy in recurrent or metastatic EBV-related nasopharyngeal carcinoma.

48. Preclinical Validation of an Advanced Therapy Medicinal Product Based on Cytotoxic T Lymphocytes Specific for Mutated Nucleophosmin (NPM1 mut) for the Treatment of NPM1 mut -Acute Myeloid Leukemia.

50. Demographics and treatment outcomes in patients with EBV+ PTLD treated with off-the-shelf EBV-specific CTL under an ongoing expanded access program in Europe: First analyses.

Catalog

Books, media, physical & digital resources